HC asks Delhi govt about black fungus medicine stocks, hearing on May 20

The Delhi High Court on Wednesday asked the Delhi Government to inform it about the stocks of the medicine used for the treatment of Black Fungus

Delhi High Court
Delhi High Court
ANI General News
1 min read Last Updated : May 19 2021 | 6:55 PM IST

The Delhi High Court on Wednesday asked the Delhi Government to inform it about the stocks of the medicine used for the treatment of Black Fungus.

A division bench of Justice Vipin Sanghi and Justice Jasmeet Singh asked the Delhi Government to give its response tomorrow on the stocks of the Amphotericin B drug and how they planned to distribute it.

The court's queries came after it was informed by petitioner and advocate Rakesh Malhotra that there is a shortage in the supply of medicines used to treat Black Fungus - a new issue in the ongoing Covid-19 pandemic.

The court also asked how there can suddenly be a shortage in supply when the drug is being manufactured locally and remarked that this cannot be a case of artificial shortage.

The Court has listed the matter for further hearing tomorrow.

Senior Advocate Rahul Mehra, appearing for the Delhi Government said that this issue is part of amicus note. It has been requisitioned from the Centre and there is a committee which meets twice a day, submitted to Rahul Mehra and said that he will come back tomorrow.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDelhi High CourtCoronavirus VaccineCoronavirus Tests

First Published: May 19 2021 | 6:53 PM IST

Next Story